Helicobacter pylori plays a causative role in the pathogenesis of gastritis, gastric atrophy, and peptic and duodenal ulcer (20) . Infection by this bacterium is also associated with an increased risk of gastric adenocarcinoma, and H. pylori is now classified as a type I human carcinogen (16) ; furthermore, a causative relationship between the presence of H. pylori and the occurrence of mucosa-associated lymphoid tissue (MALT) lymphoma was suggested (33) . The cytotoxin of H. pylori may play a central role in the pathogenesis of gastritis and gastric ulcer, but other factors are also involved. It was shown by us that sera from H. pylori-infected patients or from mice immunized with the bacterium contain autoantibodies that react with gastric mucosa of mice and humans (28) (29) (30) , and murine monoclonal antibodies (MAbs) directed against H. pylori that also react with gastric tissue (28) (29) (30) have been prepared from H. pylori-vaccinated mice. Absorption of murine and human sera with H. pylori cells removed the autoreactive antibodies (28) . Moreover, growth in mice of a hybridoma which was secreting one of the H. pylori-reactive MAbs, and which was autoreactive, caused histopathological changes similar to gastritis (28) . These (28) (29) (30) and other (11) data strongly suggest that H. pylori induces autoantibodies that play a crucial role in the pathogenesis of gastritis and gastric atrophy. Autoimmunity also may play a role in the pathogenesis of H. pylori-linked carcinoma (43) and MALT lymphoma (14, 17) . However, the nature of the bacterial antigens that induce autoimmunity are currently unknown, as are the host targets recognized. Recently, it has been shown that the O-side chain of the lipopolysaccharide (LPS) of H. pylori NCTC 11637 is structurally similar to the Lewis x blood group antigen (3, 4) present also in gastric mucosa (19) . The LPS of another strain (MO19) is structurally similar to Lewis y (2) , and that of a third (P466) contains Lewis x and Lewis y (2) (Fig. 1) .
The present paper investigates the potential role of H. pylori LPS in H. pylori-linked autoimmunity. We report that Lewis x and/or y structures are present in LPS of clinical isolates of H. pylori. Immunizations and experimental and natural infections with H. pylori yield anti-Lewis x and/or y antibodies that react with gastric tissue and have a potential pathogenic role. We also identify host autoimmune targets.
MATERIALS AND METHODS
H. pylori strains. Strain NCTC 11637 was obtained from the National Collection of Type Cultures (Public Health Laboratory Service, London, England); P466 and MO19 were obtained from T. Boren, University of Umeå, Umeå, Sweden; clinical isolates (strains 104, 474, 487, 609, 700, and 1152) were obtained from patients with gastroduodenal diseases at the University Hospital, Vrije Universtiteit, Amsterdam, The Netherlands; strain N was isolated from a patient suffering from atrophic gastritis at the Spedali Civili, Brescia, Italy.
Purified naturally occurring antigens. LPS from strain NCTC 11637 (ϭsero-type O:1 [25] ) was prepared as described previously by phenol extraction and subsequent enzymatic treatments (26) . LPSs from H. pylori serotypes O:2 to O:6 and strains P466 and MO19 were provided by J. L. Penner (University of Toronto, Toronto, Canada). The LPSs were extracted by the phenol water technique (26) , and subsequently, the extracts were digested with lysozyme plus DNase, RNase, and proteinase K and reextracted with phenol. The purity of the LPS preparations was confirmed by routine sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with silver staining for protein and LPS (39) . Schistosoma mansoni circulating cathodic antigen (CCA), a glycoprotein containing polymeric (n ϭ 25) Lewis x, was purified by affinity chromatography on an anti-CCA MAb described previously (40) . Hog and rabbit microsomes, H ϩ ,K ϩ -ATPase constituting Ͼ90% of the protein present, were prepared by sucrose gradient purification (9) . Human microsomes were prepared from gastric cardia obtained after esophagectomy performed on a patient with blood group A; mouse microsomes were prepared from C57BL/6 mice after CO 2 euthanasia. Human and mouse microsomes sedimenting to 33 and 30% sucrose, respectively (9) , were analyzed by SDS-PAGE. Rabbit H ϩ ,K ϩ -ATPase ␤ chain was prepared by lectin affinity chromatography (32) . Hog and human intrinsic factor were isolated from mucosal tissue and gastric juice, respectively, by high-pressure liquid chromatography and affinity chromatography (15) ; purity was confirmed by the observation of a single band in SDS-PAGE with silver staining. Crude mucin was obtained by scraping, following resection, of a fragment of 5 cm 2 of gastric body mucosa of a gastric carcinoma patient, followed by dilution in phosphate-buffered saline (PBS), dialyzation in a 300-kDa cutoff membrane, and filtration through a 0.2-m-pore-size membrane. Tests with H. pylori-specific MAbs showed that the mucin was not contaminated with H. pylori antigens. Bovine and human serum albumin (BSA and HSA, respectively) were purchased from Sigma Chemical Co. (St. Louis, Mo.).
Synthetic Lewis antigens used to define antibody specificities. Synthetic Lewis antigens that were obtained from Isosep AB (Tullinge, Sweden) are shown in Table 1 . Unless otherwise stated, oligosaccharides were prepared from human milk. Lewis y was prepared synthetically. p-Aminophenylethyl and acetylphenylenediamine acted as spacers between the oligosaccharides and albumin. About 20 to 25 oligosaccharide chains are linked to one molecule of HSA or BSA.
Murine MAbs. Bra.4F1 (anti-Lewis x), 12.4 (anti-Lewis y), 19-O Le (anti-H type II), 7 Le (anti-Lewis a), 2-25 Le (anti-Lewis b), and 3-3A (anti-blood group A) were obtained from Bioprobe BV, Amstelveen, The Netherlands. CS Lex (anti-sialyl Lewis x) was obtained from W. van Dijk, Vrije Universiteit. MAb 54-1-F6A is specific for CCA (40) . MAbs CB-4, CB-10, 1E52, 4D2, A540, A522, A1, and A18 (see also New Zealand Black mice were injected intraperitoneally at days 0, 14, 28, and 42 with a mixture of 0.25 ml of bacteria (10 9 CFU of strains 104 and 700) and 0.25 ml of complete Freund adjuvant (day 0) or incomplete Freund adjuvant (other days). Sera were collected at day 56. For the production of antiserum to purified LPS, Swiss mice were injected intraperitoneally (days 0, 14, 28, and 42) with 10 g of purified LPS (strain NCTC 11637), emulsified with complete Freund adjuvant (day 0) or incomplete Freund adjuvant (other days). Murine antiserum to E. coli O111:B4 cells was similarly prepared in BALB/c mice. Sera from nonimmunized BALB/c and Swiss mice were also collected. To investigate the presence of anti-Lewis x antibodies in experimentally infected mice, sera from a mouse model for H. pylori infection that mimics human disease were collected and analyzed (24) . Briefly, bacteria (fresh clinical isolates or mouse-adapted strains) were orally inoculated into male C57BL/6 mice, after which gastric colonization became established. We investigated sera from mice that had been infected with either a cytotoxin-producing strain (n ϭ 3) or a noncytotoxic strain (n ϭ 3). Preimmune sera were collected, mice were terminated after 8 weeks, and their sera were investigated.
Patient sera. The presence of anti-Lewis x and y antibodies in sera from three patient groups was investigated. One group of sera was obtained from patients who were positive (n ϭ 18) or negative (n ϭ 10) for H. pylori infection by serology (30) . Another group of sera was from patients who were positive (n ϭ 12) or negative (n ϭ 10) for H. pylori infection by culture and histology. Sera were also obtained from a group of 90 dyspeptic patients. 
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Enzyme-linked immunosorbent assay (ELISA).
For direct binding assays, bacterial cells (10 6 /ml), microsomes (5 g/ml), LPS, intrinsic factor, CCA, and synthetic Lewis antigens (all at 1 g/ml), suspended in 100 l of PBS, were added to wells of microtiter plates and incubated overnight at room temperature (RT). Plates were washed with PBS containing 0.05% Tween 80 (PBST). Subsequently, MAbs (100 ng/ml) or human sera diluted in PBST were added and incubated for 2 h at RT. Before testing in ELISA, murine and rabbit sera were diluted (for dilutions, see Results), incubated in PBST containing 0.1% HSA and 0.1% BSA (PBST-HSA-BSA) for 1 h at 37ЊC, and centrifuged (5 min, 14,000 ϫ g), and the supernatants were subsequently tested. This procedure eliminated high nonspecific background binding to PBS-, BSA-, and HSA-coated control wells. Plates were washed three times with PBST; conjugates (horseradish peroxidase-labeled goat anti-mouse immunoglobulin G [IgG] and IgM, anti-human Igs [IgG plus IgM plus IgA; American Qualex, La Mirada, Calif.]; anti-rabbit IgG [heavy plus light chain; Nordic, Tilburg, The Netherlands]) were added, diluted 1:1,000 in PBST with 0.5% goat serum, and incubated for 2 h at 37ЊC. Plates were washed, color was developed with H 2 O 2 and orthophenylene diamine in citrate-phosphate buffer (pH 5.5) for 30 min at RT, and the optical density (OD) was read at 492 nm after stopping the reaction with 50 l of sulfuric acid. The following controls were used: binding of MAbs and sera to PBS-, BSA-, and HSA-coated wells; binding of conjugate to antigen-coated wells.
The presence of anti-Lewis x antibodies in human sera was also investigated by their ability to inhibit the binding of a Lewis x MAb (CB-10) to H. pylori N. Plates were coated with 100 l of 10 5 cells of H. pylori N per ml and postcoated with PBS containing 0.5% BSA and 50% fetal calf serum (FCS) (PBS-BSA-FCS). Samples (50 l) of human sera diluted in PBS-BSA-FCS were added and incubated for 1 h at RT. Subsequently, 50 ng of biotinylated CB-10 in 50 l of PBS-BSA-FCS was added and incubated for 30 min at RT. Streptavidin-biotinhorseradish peroxidase complex was added (1:1,000 in PBS-BSA), and the ELISA was completed as described above. In this assay system, the noninhibited control value of CB-10 binding to H. pylori was adjusted to 2.8. The presence of anti-Lewis x antibodies in human serum causes inhibition, i.e., a lowered OD is observed.
SDS-PAGE and immunoblot. Microsomes were electrophoresed in a 9% polyacrylamide gel (21) Immunohistochemistry. Paraffin-embedded human gastric mucosa (corpus and antrum) was sectioned (4 m), deparaffinized, blocked for endogenous peroxidase activity with 0.3% hydrogen peroxide in methanol (30 min, RT), washed in PBS (30 min, RT), blocked with rabbit serum diluted 1:50 in PBS containing 0.1% BSA, incubated (1 h, RT) with MAbs (1 g/ml) in PBS containing 0.1% BSA, washed with PBS (30 min, RT), incubated (30 min, RT) with peroxidase-labeled rabbit anti-mouse conjugate (Dako) diluted 1:25 in PBS containing 0.1% BSA, and stained (3 min, RT) with diaminobenzidine (0.05%)-hydrogen peroxide (0.02%); the reaction was stopped in running tap water. Sections were counterstained with hematoxylin. We compared Bra.4F1 with CB-10 (conventional and H. pylori-derived anti-Lewis x MAbs, respectively; see also Table 4 ) and 12.4 with CB-4 (conventional and H. pylori-derived anti-Lewis y MAbs, respectively).
Measurement of fucosyltransferase (FT) activity. To investigate whether the occurrence of Lewis x and y antigens was concomitant with the presence of enzymes involved in their synthesis, FT activity was measured. A total of 2.3 ϫ 10 9 bacterial cells of strain 609, which expresses Lewis x and Lewis y (see Table  2 ), were sonicated (four times for 30 s each, 4ЊC), and ␣3-FT activity was measured, with Fuc␣1-2Gal␤1-4GlcNAc␤1-(CH 2 ) 8 -COOCH 3 as an acceptor (10) . In this assay, the transfer of radioactively labeled fucose from GDP-fucose to the acceptor is measured. Strains MO19 (expressing Lewis y), P466 (expressing both Lewis x and y) (2-4), and 609 were likewise investigated for ␣2-FT activity with Gal␤1-phenyl, a universal acceptor for this type of FT (34) . (Table 2) . No ␣2-FT was detected in strains 609, P466, and MO19, which is not in agreement with the established presence of Lewis y in these strains (Table 2) (2-4) .
RESULTS

Occurrence of Lewis x and y and H type I in
Immune response to H. pylori LPS. Rabbit antisera to seven H. pylori strains reacted with synthetic Lewis x and y and H type I and with purified LPS of strain NCTC 11637 (Table 3) . Table 1 ) (OD ϭ 0.9 at 1:250). Reactivity of antisera to PBS-treated wells and to BSA-or HSA-coated wells was low (OD below 0.5). Control sera (antiserum to E. coli O111 and nonimmune mouse sera) did not react with trimeric Lewis x. Sera from experimentally infected mice were tested for reactivity with trimeric Lewis x. At a dilution of 1:250, serum from one of the six mice tested reacted (OD ϭ 2.6) while none of the preimmune sera did. Previously, we have described a panel of 30 H. pylori-reactive MAbs, obtained after immunization of mice with H. pylori, of which eight were autoreactive, i.e., they reacted with human and murine gastric tissue (28) (29) (30) . We tested this panel for binding with Lewis antigens. The eight autoreactive MAbs reacted: four of them (A522, A1, A18, and CB-10) proved to be specific for Lewis x, three (A540, CB-4, and 1E52) were specific for Lewis y, and one (4D2) was specific for H type I ( Table 4) . None of the nonautoreactive MAbs tested bound to Lewis antigens or H. pylori LPS. Thus, H. pylori LPS is also immunogenic in mice, and MAbs to Lewis antigens may be prepared from H. pylori-immunized mice.
Human antibody response. Sera from H. pylori patients (n ϭ 18) and noninfected controls (n ϭ 10) (defined by serology) were tested for binding with the currently available purified LPS from H. pylori NCTC 11637, O1 to O6, P466, and MO19. The highest OD reached on any of the LPSs is shown in Fig.  2a . Patient sera reacted with ODs ranging from 0.2 to Ͼ2.6, while control sera reacted much less (0.2 to 0.4). A second group of H. pylori patients (n ϭ 12) and controls (n ϭ 10), defined by culture and histology, yielded similar data (not shown). These data show that H. pylori LPS is immunogenic in humans. The reactivity of one patient serum with three different LPSs is shown in Fig. 2b . The serum reacts with LPS of strains NCTC (expressing Lewis x) and P466 (Lewis x and Lewis y) but not with LPS of strain MO19 (Lewis y). Several sera (data not shown) reacted with LPS of strains NCTC 11637 and P466 and also with LPS of strain MO19. To further define the epitope specificity of the human antibody response to H. pylori LPS, patient sera were tested for binding with Lewis x and CCA, which contains polymeric Lewis x. An example is given in Fig. 2c . The patient serum reacted well with CCA but much less with trimeric Lewis x or monomeric Lewis x. We also investigated the presence of anti-Lewis x antibodies in the sera by another method, i.e., by the ability of the sera to inhibit the binding of a Lewis x MAb (biotinylated CB-10) to H. pylori. At first, for comparison, we tested a group of sera from 90 dyspeptic patients both in inhibition and for reactivity with NCTC 11637 LPS, which expresses Lewis x. Figure 2d shows that the ability of sera to inhibit correlated with their reactivity with the LPS (r ϭ Ϫ0.82, P Ͻ 0.0001). Three patient serum samples, highly reactive with LPS and indicated with asterisks in Fig. 2a , strongly inhibited the binding of biotinylated CB-10. The noninhibited OD was 2.8; the three serum samples reduced this value to 0.1. We conclude that H. pylori LPS elicits antibodies to Lewis x in humans.
Comparison of Lewis x MAbs induced by H. pylori and conventional anti-Lewis x MAbs. In FACS analysis of binding with human PMN, the H. pylori-derived anti-Lewis x MAb CB-10 reacted comparably with Bra.4F1, a conventional Lewis x-specific MAb (Fig. 3) . Likewise, in immunohistochemistry, the reactivity of H. pylori-induced anti-Lewis x and y (CB-10 and CB-4, respectively) MAbs was comparable with that of the conventional anti-Lewis x and y MAbs (Bra.4F1 and 12.4, respectively) (Fig. 4) . Anti-Lewis x and y MAbs react with the glandular epithelium, but anti-Lewis x MAbs are reactive with a more restricted area. Furthermore, cells from one of three patients with gastric MALT lymphoma reacted with CB-4. MAbs CB-4 and CB-10 also reacted with gastric adenocarcinoma cells of one of three patients tested (not shown). We conclude that H. pylori-induced antibodies to Lewis antigens bind to host cells.
Identification of autoimmune targets. Previously, we have shown that human and murine H. pylori-induced antibodies are directed against gastric foveolar secretions and intracellular mucin of foveolar and neck cells, chief cells, and canaliculi of parietal cells (28) (29) (30) , but the molecular species remained unidentified and we do not know if one or more species are involved. We tested a variety of anti-Lewis MAbs for binding with gastric mucin, with intrinsic factor, and with gastric H ϩ ,K ϩ -ATPases. Both intrinsic factor and the ␤ chain of gastric H ϩ ,K ϩ -ATPase are glycoproteins synthesized by the gastric parietal cells and are known targets in gastric autoimmunity (15, 22, 38) . The results shown in Table 5 indicate that there is serological evidence for the presence of Lewis x and y in gastric mucin (also a glycoprotein) and for Lewis y and H type I in pig and rabbit H Pathogenic role of H. pylori LPS-induced anti-Lewis antibodies. In a previous study, we have described that growth during 2 weeks in mice of an H. pylori-induced hybridoma (CB-4) that secretes autoantibodies causes gastric histopathological changes, similar to those occurring during gastritis, e.g., infiltration with inflammatory cells (28) . However, this did not occur upon growth in vivo of a control hybridoma. Thus, a causative role for H. pylori-induced autoantibodies in the disease process was demonstrated. In this study, we determined that the MAb tested in vivo (CB-4) is specific for Lewis y (Table 4) .
DISCUSSION
In this paper, we have shown that Lewis x and y and H type I (for structures, see Table 1 ), which are common epitopes on 
a See Table 2 . -, OD Ͻ 0.3; Ͼ, OD above 2.7. b See Table 3 for antigen abbreviations.
H. pylori LPS, induce autoantibodies in animals and humans.
We also have identified a potential target of the autoimmune response, i.e., gastric H ϩ ,K ϩ -ATPase, the proton pump. Finally, we have shown that H. pylori-induced anti-Lewis y antibodies may cause gastric immunohistopathological changes.
Lewis x, structurally present in H. pylori LPS (2-4), was also detectable by serology (Table 2) (7, 35) . Lewis y is present structurally (2, 4) and can be detected by serology (Table 2) ; H type I is as yet detectable by serology only. Striking is the difference in reactivity of two anti-Lewis x MAbs, CB-10 and 54-1-F6A (Table 2) , a MAb obtained after immunization with Schistosoma spp. Our data demonstrate cross-reactivity between H. pylori LPS and Schistosoma CCA, which is based on the presence of polymeric Lewis x (3, 4, 40) . ␣3-FT activity was detected in strain 609; the presence of ␣3-FT has been reported before (7) . In contrast, no ␣2-FT activity was detected in Lewis y-containing strains despite use of Gal␤-1-phenyl, the most general acceptor for ␣2-FT. Thus, H. pylori ␣2-FT behaves unlike the most well known ␣2-FT enzymes (34) .
We now have developed a serotyping system for H. pylori based on the occurrence of Lewis epitopes; more than 85% of strains obtained from various parts of the world and from various disease entities expressed Lewis antigens (36) . Thus, Lewis antigens are common antigens on H. pylori.
Rabbit antisera to six H. pylori strains reacted strongly with Lewis x; antiserum to strain 487 reacted with H type I and (Table 4 ) and H. pylori LPS and cross-reacted with murine and human gastric mucosa. MAbs (n ϭ 22) to other H. pylori antigens did not bind to gastric mucosa, and we conclude that only LPS was responsible for the H. pylori-induced gastric cross-reactivity in the mouse, reported by us before (28) (29) (30) . Compared with control sera, sera from H. pylori patients reacted much more strongly with H. pylori LPS (Fig. 2a) . Serum from a patient from whom a strain expressing both Lewis x and y was isolated reacted strongly with LPS of strain NCTC 11637 (Lewis x) but not with LPS of strain MO19 (Lewis y) (Fig. 2b) . Why in this case no anti-Lewis y response can be detected is currently not understood. The binding of patient sera to schistosomal CCA (ϭpolymeric Lewis x) was much lower compared with the LPS response (compare Fig. 2b and c) , and binding to trimeric and monomeric Lewis x was virtually zero. Possibly, a major fraction of the human serum response is directed to non-Lewis epitopes present in the LPS core region (2-4). We also obtained evidence for an anti-Lewis x response in humans by measuring the ability of human sera to inhibit the binding of a biotinylated anti-Lewis x MAb (CB-10) with H. pylori LPS, and several sera that reacted well with LPS of strain NCTC 11637 (Lewis x) were strongly inhibitory (Fig. 2a) . The ability of sera to inhibit was concomitant with their inhibitory power (Fig. 2d) . In summary, infected patients react to H. pylori LPS with an anti-Lewis x response as measured by binding to purified, Lewis x-containing LPS and to CCA and by inhibition of an anti-Lewis x MAb. H. pylori-induced anti-Lewis x bound well to PMN (Fig. 3) , cells known to express Lewis x (CD15). The glandular region of human gastric epithelium was recognized by anti-Lewis x and anti-Lewis y MAbs (Fig. 4) . Finally, in one of three cases tested, human gastric adenocarcinoma cells and MALT lymphoma cells reacted with H. pylori-induced anti-Lewis MAbs. In previous studies, we have shown (28) (29) (30) that sera from mice immunized with H. pylori and sera from infected patients bind also to the glandular region (parietal cells, mucus-producing cells) and that this binding disappeared after absorption with H. pylori cells (Ͻ10% coccoid forms present). We hypothesized that H. pylori LPS-induced antibodies reactive with gastric Lewis antigens are involved in this autoimmune reaction. The gastric parietal cell is a known target for autoimmune antibodies; in particular, the H ϩ ,K ϩ -ATPase gastric proton pump, a heterodimeric enzyme (␣ and ␤ chains) that acidifies the stomach and is localized in the parietal canaliculi, may be recognized by autoantibodies (18) . Correlation between patient serum antibody titers to H. pylori and to H ϩ ,K ϩ -ATPase has been reported previously (23) . More-detailed studies showed that the ␤ subunit (22, 38) , including its oligosaccharide chain (13, 44) , is involved in autoimmunity. Recent structural work has shown that the glycan part is composed of galactose, fucose, and N-acetylglucosamine (44) in the form of polylactosamine structures, i.e., similar to Lewis antigens (6) . Taken all together, we hypothesized that the glycan chain of the gastric H ϩ ,K ϩ -ATPase ␤ chain is one of the targets of H. pylori LPS-induced anti-Lewis autoimmunity. Supportive data (Table  5 and Fig. 5) show the presence of Lewis y in the ␤ chain of gastric H ϩ ,K ϩ -ATPases of pigs, rabbits, mice, and humans. The pig and mouse ␤ units also expressed H type I and Lewis x, respectively. A second well-recognized parietal cell glycoprotein autoantigen, intrinsic factor, did not express Lewis antigens. A crude gastric mucin preparation expressed Lewis x and y antigens (Table 5 ), but this observation requires validation with fully purified material.
In the past (28), we have tested the effect of high concentrations of autoreactive MAbs in vivo in the murine host by allowing growth of an H. pylori-derived autoreactive hybridoma. Results of these experiments showed immunohistopathological aberrations, similar to gastritis in the form of inflammatory cell infiltrates and enhanced degenerative and regenerative processes (28) . In the present study, we prove that the epitope specificity of that particular MAb (CB-4) is Lewis y (Table 4) (43) . This may be true for MALT lymphoma cells, too (14) . An alternative mechanism by which H. pylori might be involved in the pathogenesis of MALT lymphoma is the ability of Lewis x itself to cause B-cell proliferation (42) . Thus, the molecular mimicry that exists between H. pylori LPS and host glycoconjugates may give rise to autoimmune phenomena. In this respect, the case of H. pylori is not unique. Autoimmunity due to molecular mimicry between bacteria and host has been documented, as has the involvement of glycoproteins and glycolipids (12) . An example relevant to the present study is Campylobacter jejuni. The molecular structure of C. jejuni LPS mimics that of gangliosides (1) and elicits antibodies that react with gangliosides, a process which is believed to be central to the pathogenesis of the autoimmune neurodegenerative Guillain-Barré syndrome.
To conclude, upon infection with H. pylori an anti-Lewis x and/or y antibody response develops, one that is directly involved in gastritis and possibly later in parietal cell damage. Within this concept, type B gastritis also and possibly H. pyloriassociated malignancies have an autoimmune component. Our findings are also relevant to the design of H. pylori vaccines to avoid an autoimmune response. Thus, molecular mimicry between H. pylori LPS and human Lewis x and y antigens may play a pivotal role in H. pylori-linked disease. Table 3 for specificity abbreviations.
